ArticleTranslational vision science & technology2025
Code-Free Machine Learning for the Detection of Common Ophthalmic Diseases.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Purpose: We explore a code-free method enabling physicians without programming experience to develop machine learning (ML) models for detecting diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma from fundus photographs. Methods: Two classification models were developed using Google Vertex AI's no-code AutoML Vision platform: a binary model detecting any pathology and a multi-class model classifying specific diseases. The development dataset consisted of 800 fundus photography images (200 each of DR, AMD, glaucoma, and normal) from the publicly available Fundus Image dataset for Vessel Segmentation. Ten percent of the dataset was saved for testing and 10% for internal validation. External validation was performed using the Eye Disease Diagnosis and Fundus Synthesis dataset, from which 100 single-diagnosis images per class were randomly selected (total N = 400). Model performances were evaluated using area under the precision-recall curve (AUPRC), precision, recall, accuracy, F1 score, and confidence score analysis. Results: Internally, the binary model yielded an AUPRC of 0.967, with 95.0% precision and recall. The multi-class model had an AUPRC of 0.906, with 91.0% precision and 90.0% recall. On external validation, the binary model reached 92.3% accuracy, whereas the multi-class model achieved 90% overall accuracy. Conclusions: Code-free ML approaches can enable physicians to create ML models for retinal disease detection without requiring programming expertise, supporting early detection of eye diseases. Translational Relevance: This work bridges the gap between AI research and clinical deployment by demonstrating that physicians can independently build ML models using accessible, no-code tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.